ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Scorpius Holdings, Inc. (SCPX) stock declined over -3.67%, trading at $0.16 on AMEX, down from the previous close of $0.17. The stock opened at $0.17, fluctuating between $0.16 and $0.17 in the recent session.
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
Employees | 82 |
Beta | 0.03 |
Sales or Revenue | N/A |
5Y Sales Change% | -0.884% |
Fiscal Year Ends | N/A |
Sector | Healthcare |
Industry | Biotechnology |